Benjamin Oakes
CEO
Scribe
Bio:
Benjamin Oakes, Ph.D., is co-founder and CEO of Scribe Therapeutics, a genetic medicines company unlocking the potential of CRISPR to transform human health.
Previously, Dr. Oakes was an Innovative Genomics Institute Entrepreneurial Fellow, received a Ph.D. in Molecular and Cellular Biology from the University of California, Berkeley, and worked in the lab of Nobel Laureate and CRISPR co-inventor Jennifer Doudna.
Dr. Oakes and his Scribe team pioneered CRISPR by Design™, a data-driven design and engineering process, to enable a new era of in vivo CRISPR-based standard of care treatments for patients with highly prevalent diseases.